Thursday, July 7, 2022

Tag: ExCITE

Geoffrey Clark, Ph.D.
Business & Economy

UofL technology that may inhibit pathway for cancer gets commercial partner...

Baylee Pulliam -
NA University of Louisville-born invention that may help treat cancer now has a commercial partner. Qualigen Therapeutics Inc., a California biotechnology company focused on developing...
An $4 million grant received by the University of Louisville, the University of Kentucky, Commonwealth Commercialization Center (C3) and the Kentucky Cabinet for Economic Development advance the most promising biomedical research innovations.
Education & Leadership

UofL receives groundbreaking new grant to spark commercialization of health research...

Betty Coffman -
An elite $4 million grant received by the University of Louisville, the University of Kentucky, Commonwealth Commercialization Center (C3) and the Kentucky Cabinet for...
Innovative Therapeutix Inc. co-founder Michael Detmer (center) poses after winning the 2018 Venture Sharks business pitch competition, along with University of Louisville staff from the Office of Technology Transfer, ExCITE and the NSF Innovation Corps site program.
Business & Economy

UofL-backed teams swim with the ‘sharks’ (and win)

Baylee Pulliam -
University of Louisville-backed startups scored a one-two finish in this year’s “Venture Sharks” business pitch competition held on May 2. The companies, Innovative Therapeutix Inc....